Javascript must be enabled to continue!
Abstract 9772: Paroxysmal Atrial Fibrillation Among Pulmonary Embolism Patients; Insight From the 2019 National Inpatient Sample
View through CrossRef
Introduction:
Various factors can trigger events of Pulmonary Embolism(PE). Several studies have linked cardiac arrhythmias such as Paroxysmal Atrial Fibrillation (PAF) with a higher risk of multiple cardiovascular and pulmonary complications. As there is a paucity of data on the risk factors for an event of PAF among PE patients and the factors contributing to death, we conducted a retrospective analysis using the 2019 National Inpatient Sample(NIS).
Methods:
Our study focused on finding patients with a principal diagnosis of Pulmonary Embolism and a diagnosis of Paroxysmal Atrial Fibrillation. A multivariable regression model evaluated several risk factors for PAF incidence among PE patients and their possible mortality risks.
Results:
A total of 188,850 cases of PE were observed in our study, including 9,960 (5.3%) cases of PAF. Hyperlipidemia (aOR 1.348, 95% CI 1.290-1.409, p<0.01), hypertension (aOR 1.988, 95% CI 1.887-2.095, p<0.01), and old myocardial infarct (aOR 1.574, 95% CI 1.463-1.693, p<0.01) predisposed to PAF among PE, while females (aOR: 0.873, 95% CI 0.837-0.910, p<0.01), patients with obesity (aOR 0.858, 95% CI 0.818-0.900, p<0.01), and those classified as racially Black (aOR 0.603, 95% CI 0.534-0.681, p<0.01), and Hispanic (aOR 0.653, 95% CI 0.562-0.758, p<0.01) (compared to group excluding Whites, Blacks and Hispanics) reduced their risk. An in-hospital mortality rate of 4.0% was also estimated as 395 patients with PAF died. PAF patients with PE had a higher chance of dying if they also had a diagnosis of diabetes (aOR 1.347, 95% CI 1.070-1.695, p=0.011), whereas those who were obese (aOR 0.421, 95% CI 0.311-0.570, p<0.01), with hyperlipidemia (aOR 0.732, 95% CI 0.590-0.909, p<0.01), and smokers (aOR 0.751, 95% CI 0.606-0.931, p<0.01) expressed a lower risk of mortality. PAF patients with PE reported a higher overall risk of death during hospitalization (aOR 1.322, 95% CI 1.190-1.469, p<0.01).
Conclusions:
Patients with a diagnosis of PAF while admitted with PE showed a higher risk of mortality. Several factors influenced the presence of PAF among PE patients. It is thus essential for physicians to monitor various cardiovascular complications and arrhythmias in patients admitted with PE.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 9772: Paroxysmal Atrial Fibrillation Among Pulmonary Embolism Patients; Insight From the 2019 National Inpatient Sample
Description:
Introduction:
Various factors can trigger events of Pulmonary Embolism(PE).
Several studies have linked cardiac arrhythmias such as Paroxysmal Atrial Fibrillation (PAF) with a higher risk of multiple cardiovascular and pulmonary complications.
As there is a paucity of data on the risk factors for an event of PAF among PE patients and the factors contributing to death, we conducted a retrospective analysis using the 2019 National Inpatient Sample(NIS).
Methods:
Our study focused on finding patients with a principal diagnosis of Pulmonary Embolism and a diagnosis of Paroxysmal Atrial Fibrillation.
A multivariable regression model evaluated several risk factors for PAF incidence among PE patients and their possible mortality risks.
Results:
A total of 188,850 cases of PE were observed in our study, including 9,960 (5.
3%) cases of PAF.
Hyperlipidemia (aOR 1.
348, 95% CI 1.
290-1.
409, p<0.
01), hypertension (aOR 1.
988, 95% CI 1.
887-2.
095, p<0.
01), and old myocardial infarct (aOR 1.
574, 95% CI 1.
463-1.
693, p<0.
01) predisposed to PAF among PE, while females (aOR: 0.
873, 95% CI 0.
837-0.
910, p<0.
01), patients with obesity (aOR 0.
858, 95% CI 0.
818-0.
900, p<0.
01), and those classified as racially Black (aOR 0.
603, 95% CI 0.
534-0.
681, p<0.
01), and Hispanic (aOR 0.
653, 95% CI 0.
562-0.
758, p<0.
01) (compared to group excluding Whites, Blacks and Hispanics) reduced their risk.
An in-hospital mortality rate of 4.
0% was also estimated as 395 patients with PAF died.
PAF patients with PE had a higher chance of dying if they also had a diagnosis of diabetes (aOR 1.
347, 95% CI 1.
070-1.
695, p=0.
011), whereas those who were obese (aOR 0.
421, 95% CI 0.
311-0.
570, p<0.
01), with hyperlipidemia (aOR 0.
732, 95% CI 0.
590-0.
909, p<0.
01), and smokers (aOR 0.
751, 95% CI 0.
606-0.
931, p<0.
01) expressed a lower risk of mortality.
PAF patients with PE reported a higher overall risk of death during hospitalization (aOR 1.
322, 95% CI 1.
190-1.
469, p<0.
01).
Conclusions:
Patients with a diagnosis of PAF while admitted with PE showed a higher risk of mortality.
Several factors influenced the presence of PAF among PE patients.
It is thus essential for physicians to monitor various cardiovascular complications and arrhythmias in patients admitted with PE.
Related Results
ASSA13-02-26 Stroke in young patients with paroxysmal supraventricular tachycardia: A report of two cases of thromboembolic stroke
ASSA13-02-26 Stroke in young patients with paroxysmal supraventricular tachycardia: A report of two cases of thromboembolic stroke
Abstract
Paroxysmal Supraventricular Tachycardia (PSVT) is the most common type of sustained tachycardia in healthy adults. It is generally believed that thromboe...
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
It has been appreciated for a long time that atrial flutter and atrial fibrillation have a clinical relationship. Now, with the technological advances that permit more sophisticate...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Adiponectin and Lone atrial fibrillation
Adiponectin and Lone atrial fibrillation
Objective: Lone atrial fibrillation is an idiopathic arrhythmia seen in younger individuals without any secondary disease. Adiponectin is an endogenous adipocytokine that increases...
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
ASSA13-03-9 Decreased Expression of Small-Conductance Ca2+-Activated K+ Channels SK1, SK2, and SK3 in Patients with Persistent Atrial Fibrillation
Background
Small-conductance Ca2+-activated K+ channels (SK channels) have been reported involved in atrial fibrillation (AF) as a new ion channel candidates, as ...
Genetic markers and traditional risk factors in predicting atrial fibrillation in patients with arterial hypertension, focus on the renin-angiotensin-aldosterone system genes
Genetic markers and traditional risk factors in predicting atrial fibrillation in patients with arterial hypertension, focus on the renin-angiotensin-aldosterone system genes
BACKGROUND: Genetic and environmental factors are involved in the development of atrial fibrillation in arterial hypertension. This determines the relevance of studying gene-enviro...
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Beyond Coronary Risk: Clinical Scores as Predictors of Atrial Fibrillation in Chronic Coronary Syndrome
Atrial fibrillation frequently coexists with chronic coronary syndrome, sharing common cardiovascular risk factors and pathophysiological mechanisms. Identifying patients with chro...
ASSA13-02-23 Relationship of Thickness of Left Atrial Epicardial Adipose Tissue and Atrial Fibrillation
ASSA13-02-23 Relationship of Thickness of Left Atrial Epicardial Adipose Tissue and Atrial Fibrillation
Background
Obesity is an important risk factor for atrial fibrillation (AF). Epicardial adipose tissue in close anatomic proximity to cardiac structures and auton...

